Genemate Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.90 M
as on 03-01-2025
- Revenue 12.01%
(FY 2020)
- Profit 59.71%
(FY 2020)
- Ebitda 159.41%
(FY 2020)
- Net Worth 17.43%
(FY 2020)
- Total Assets 70.55%
(FY 2020)
About Genemate Technologies
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Heerendra Shishodia and Sangeeta Singh serve as directors at the Company.
- CIN/LLPIN
U29297DL2002PTC114968
- Company No.
114968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Genemate Technologies Private Limited offer?
Genemate Technologies Private Limited offers a wide range of products and services, including Laboratory Centrifuge, Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems.
Who are the key members and board of directors at Genemate Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Heerendra Shishodia  | Director | 15-Apr-2002 | Current |
| Sangeeta Singh | Director | 15-Apr-2002 | Current |
Financial Performance of Genemate Technologies.
Genemate Technologies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 12.01% increase. The company also saw a substantial improvement in profitability, with a 59.71% increase in profit. The company's net worth Soared by an impressive increase of 17.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genemate Technologies?
In 2017, Genemate Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 12 Oct 2007 | ₹0.90 M | Open |
How Many Employees Work at Genemate Technologies?
Unlock and access historical data on people associated with Genemate Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genemate Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genemate Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
